Nanobiotix S.A.
NANO.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €142,741 | €244,081 | €126,164 | €253,901 |
| - Cash | €49,737 | €75,283 | €38,576 | €83,921 |
| + Debt | €50,902 | €50,565 | €53,168 | €46,020 |
| Enterprise Value | €143,906 | €219,363 | €140,756 | €216,000 |
| Revenue | -€11,609 | €30,058 | €4,776 | €10 |
| % Growth | -138.6% | 529.4% | 47,660% | – |
| Gross Profit | -€11,609 | €30,058 | €3,276 | €2,647 |
| % Margin | 100% | 100% | 68.6% | 26,470% |
| EBITDA | -€61,624 | -€30,085 | -€53,785 | -€45,605 |
| % Margin | 530.8% | -100.1% | -1,126.2% | -456,050% |
| Net Income | -€68,132 | -€39,700 | -€57,041 | -€47,003 |
| % Margin | 586.9% | -132.1% | -1,194.3% | -470,030% |
| EPS Diluted | -1.44 | -1.08 | -1.64 | -1.35 |
| % Growth | -33.3% | 34.1% | -21.5% | – |
| Operating Cash Flow | -€19,551 | -€12,476 | -€38,019 | -€31,004 |
| Capital Expenditures | -€846 | -€328 | -€93 | -€233 |
| Free Cash Flow | -€20,399 | -€12,813 | -€38,112 | -€31,237 |